Schizophrenia Trials in Marietta, United States
Conditions / Schizophrenia / Marietta, United States
Schizophrenia is a medical condition with active clinical research programs worldwide.
22 total trials for this combination
Showing top 10 of 22 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01714713 | A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy | COMPLETED | PHASE3 |
| NCT02970305 | Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE) | COMPLETED | PHASE2 |
| NCT00528905 | Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia | COMPLETED | PHASE2 |
| NCT01432444 | Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole | COMPLETED | PHASE3 |
| NCT05304767 | An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia | RECRUITING | PHASE3 |
| NCT05859698 | Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia | COMPLETED | PHASE4 |
| NCT03893825 | A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia | COMPLETED | PHASE3 |
| NCT01716975 | Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy | COMPLETED | PHASE3 |
| NCT05145413 | A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia | COMPLETED | PHASE3 |
| NCT07105111 | A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor | RECRUITING | — |